Waldencast logo

WaldencastNASDAQ: WALD

Profile

Country:

United States

IPO:

12 May 2021

Next earnings report:

N/A

Last dividends:

N/A

Next dividends:

N/A
$441.58 M
-68%vs. 3y high
42%vs. sector
-vs. 3y high
-vs. sector
-93%vs. 3y high
25%vs. sector
-vs. 3y high
-vs. sector

Price

after hours | Thu, 21 Nov 2024 00:18:59 GMT
$3.60$0.00(0.00%)

Dividend

No data over the past 3 years
$70.54 M$68.74 M

Analysts recommendations

Institutional Ownership

WALD Latest News

Waldencast Reports Q3 2024 Financial Results
globenewswire.com20 November 2024 Sentiment: POSITIVE

$70.2 million of Net Revenue Q3 2024+34.6% Comparable Net Revenue GrowthBoth brands accelerating from Q2 2024+45.5% Obagi Medical and +23.5% Milk Makeup vs Q3 2023Adjusted EBITDA of $11.4 million, up +134.0% vs Q3 2023

Waldencast plc Announces Board Appointments and Annual General Meeting
globenewswire.com07 October 2024 Sentiment: POSITIVE

NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, announced today that Hind Sebti, Kelly Brookie and Roberto Thompson have been appointed to its board of Directors (the “Board”), effective September 26, 2024. These executives bring extensive professional experience further enhancing the breadth of talent and expertise possessed by the Board. Ms. Brookie will replace Sarah Brown who has informed the Board of her intention to not renew her mandate ahead of the Company's Annual General Meeting. The Company also announced that its Annual General Meeting is scheduled for October 28, 2024 during which the Company's shareholders will be asked to vote on the renewal of Class I and Class II directors. Following this announcement, the Board will include 11 members, each of whom possesses significant expertise, particularly in the beauty, financial and consumer products sectors.

Obagi Medical Announces the Launch of ELASTIDERM® Lift Up & Sculpt Facial Moisturizer and ELASTIDERM® Advanced Filler Concentrate
globenewswire.com09 September 2024 Sentiment: POSITIVE

These New Products are the Latest Innovation to Obagi's ELASTIDERM® Collection These New Products are the Latest Innovation to Obagi's ELASTIDERM® Collection

Why Waldencast Stock Is Skyrocketing Today
fool.com28 August 2024 Sentiment: POSITIVE

Waldencast posted Q2 sales that came in far above the market's expectations. Comparable sales growth accelerated significantly on a sequential quarterly basis.

Waldencast Reports Q2 2024 Financial Results
globenewswire.com27 August 2024 Sentiment: POSITIVE

$63.3 million of Net Revenue Q2 2024 +25.7% net revenue Comparable Growth: +30.9% Obagi Medical and +20.0% Milk Makeup vs Q2 2023 Adjusted EBITDA of $6.3 million, up +64.5% vs Q2 2023

Waldencast plc Provides Second Quarter and First Half Fiscal 2024 Earnings Conference Call and Webcast Information
globenewswire.com21 August 2024 Sentiment: POSITIVE

NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, provided second quarter and first half fiscal 2024 earnings conference call and webcast information. As previously announced, the Company will report second quarter and first half fiscal 2024 earnings on August 27th, after the close of the U.S. stock market. The Company will conduct a conference call to discuss its earnings results on Wednesday, August 28, 2024 at 8:30am ET.

4 Cosmetics Stocks Worth Watching Amid Industry Challenges
zacks.com14 August 2024 Sentiment: POSITIVE

The Zacks Cosmetics industry is grappling with elevated inflationary pressures. Coty, Inter Parfums (IPAR), Waldencast (WALD) and Olaplex (OLPX) are capitalizing on digital advancements and innovative strategies.

Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates
globenewswire.com27 June 2024 Sentiment: POSITIVE

WHITE PLAINS, N.Y., June 27, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced upcoming earnings release, conference call and webcast dates.

What type of business is Waldencast?

Waldencast plc operates in the beauty and wellness industry. It engages in developing, acquiring, accelerating, and scaling various brands. The company provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. It also offers clean makeup products under the Milk Makeup brand. The company sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners. Waldencast plc was incorporated in 2020 and is headquartered in White Plains, New York.

What sector is Waldencast in?

Waldencast is in the Consumer Defensive sector

What industry is Waldencast in?

Waldencast is in the Household & Personal Products industry

What country is Waldencast from?

Waldencast is headquartered in United States

When did Waldencast go public?

Waldencast initial public offering (IPO) was on 12 May 2021

What is Waldencast website?

https://www.waldencast.com

Is Waldencast in the S&P 500?

No, Waldencast is not included in the S&P 500 index

Is Waldencast in the NASDAQ 100?

No, Waldencast is not included in the NASDAQ 100 index

Is Waldencast in the Dow Jones?

No, Waldencast is not included in the Dow Jones index

When was Waldencast the previous earnings report?

No data

When does Waldencast earnings report?

Next earnings report date is not announced yet